Autologous peripheral blood stem cell (PBSC) transplantation is a 'rescue' of patient's self hematopoietic stem cells (HPSC) from myeloablative effects of chemotherapy or irradiation. These HPSC are either cryopreserved or liquid preserved and reinfused to repopulate the patient's marrow after myeloablation. Cryopreservation of HPSC using 5% to 10% dimethyl sulphoxide (DMSO) as a cryoprotectant under liquid nitrogen storage conditions (-196°C) for long-term usage is a well-established procedure. Liquid preservation of stem cells is usually done for 24 hours at 2°C to 6°C without agitation. 1 There are very few reports regarding the effect of liquid preservation of adult stem cells beyond 24 hours. We present 3 cases of successful engraftment of autologous HPSC after their extended storage at 4°C for 36 to 96 hours.
Baxter Healthcare, Deerfield, IL] on day -3 and -1, respectively. For obtaining an optimum dose of HPSC, a mean of 10.71 L (10.31 to 11.0) and 9.08 L (9.0 to 9.25) of blood was processed in the first and second harvest respectively. The first and second harvests were stored at 4°C for 72 to 96 hours and 36 to 48 hours, respectively. An additional 200/mL of plasma was collected for the first harvest, as it had to be stored for a longer duration. After the second PBSC collection, the patient was given high-dose melphalan (175 mg/m 2 ). Reinfusion of the autologous HPSC was done after 24 hours of myeloablative chemotherapy. The changes in mononuclear cell counts (MNC)/kg body weight at 4°C storage was assessed by automated cell counter and Giemsa stained peripheral smears of the harvests. Post-storage CD34-positive HPSC were analyzed using FITC tagged anti CD34-positive monoclonal antibody by flow cytometry. The viability of MNC was assessed by 0.4% trypan blue dye exclusion test (Sigma Chemicals). Before transfusion of stem cells, aliquots were also sent for bacterial and fungal cultures. Complete blood counts were monitored daily to study the time of hematopoietic reconstitution or engraftment.
Results
Short-term storage at 4°C mainly resulted in loss of polymorphs. Post-storage lympho-mononuclear recoveries of first and second harvests were 65.23% and 57.9%, respectively. Mononuclear cell count (MNC)/kg increased from 4.43 × 10 8 before storage at 4°C to 4.79 × 10 8 in the first harvest. However, a non-significant decrease using unpaired t test (P >0.05) was observed after second harvest from 2.81 × 10 8 to 2.48 × 10 8 /kg body weight. The harvest details are shown in Storage of peripheral blood stem cells for 24 hours at 4ºC is a well-established procedure; however, there is scarce literature on viability of stem cells if these are liquid preserved beyond 24 hours.
We did extended storage of 6 autologous peripheral blood stem cell harvests up to 96 hours at 4ºC and found good recovery in terms of mean CD34 positive cells (11.9×10 6 /kg body weight in first harvest and 5.36×10 6 /kg body weight in second harvest) and viability by 0.4% trypan blue dye exclusion test [>85% viability in first harvest (stored up to 96 hours) and > 90% viability in second harvest (stored up to 48 hours)].
Early engraftment of these stem cells [mean leucocyte engraftment (ANC >500/µL) occurred on day +11 and platelet (> 20,000/µL) on day +14] was observed in 3 patients of multiple myeloma undergoing peripheral blood autologous stem cell transplantation.
>85% in the first harvest (storage time 72 to 96 hours) and >90% in the second harvest (storage time 36 to 48 hours). The culture reports were found sterile for all the harvests. CD34-positive cell counts were done only in post-storage samples from both the harvests. The mean was found to be 11.9 × 10 6 /kg and 5.36 × 10 6 /kg from the first and second harvest respectively. The minimum dose of 2 × 10 8 MNC/kg or 2 × 10 6 /kg CD34-positive cells is required for early engraftment. 1 Both the harvest doses were above the minimum recommended values. Extended storage liquid-preserved stem cells were successfully engrafted. The mean leucocyte engraftment (ANC >500/µL) occurred on day +11 (9 to 12) and platelet (>20,000/µL) on day +14 (13 to 15) respectively.
Discussion
Cryopreservation of PBSC is done at -196°C for long-term storage (in years) whereas liquid preservation at 4°C is for shortterm storage (usually 24 hours) and in cases where myeloablative chemotherapy has a short half-life. 2 Few case reports indicate that PBSC, if stored for extended incubation of up to 72 hours at 4°C without cryopreservation, also successfully retain their engraftment potential. 2, 3 Extended incubation increases flexibility as processing and transport of these units can be done over weekends and holidays. Refrigeration storage of marrow has the advantage that it requires no special equipment or technical expertise as compared to cryopreservation and thus represents a simple and cost-effective option. In a study by Lasky and colleagues, 4 liquid preservation of unseparated human bone marrow was evaluated at 4°C, 22°C, and 37°C. The authors found good viability and proliferative potential of committed and multipotent progenitors using the trypan blue dye exclusion test and the clonal assay of various colony forming units (CFU-GM, BFU-E, CFU-E and CFU-MIX), respectively, at various temperatures. The above parameters were best maintained for a period of 3 days, only at 4°C or 22°C, but declined rapidly after 1 day at 37°C. In a study by Ahmed and colleagues, 5 the efficacy, safety, and cost efficiency of bone marrow transplantation after refrigeration and cryopreservation was compared. No difference in engraftment time either for WBC or platelets was observed.
Mobilized PBSC are routinely cryopreserved or reinfused after 24 hours of storage at 4°C following myeloablative chemotherapy. A recent study by Moroff and colleagues 6 showed that even after extended liquid storage (72 hours at 4°C); the PBSCs retained their cellular properties. There was no significant difference in nucleated cell counts, viability, CD34-positive cells, committed progenitor colonies, and long-term culture initiating cells in PBSCs which were either immediately cryopreserved for 1 to 1½ years or after liquid storage for 72 hours. Good engraftment kinetics of HPSC was observed even on extended incubation for 96 hours at 4°C in the cases studied thus confirming above observations. We observed that the additional 200 mL of plasma in the first harvest provided nutritional support and helped in maintaining HPSC morphology better as compared to the second harvest in which no plasma was added.
Thus, cryopreservation of HPSC using dimethyl sulphoxide (DMSO) is an option for long-term preservation. Short duration liquid preservation at 4°C for 72 to 96 hours maintains their viability with good recovery and is a cost-effective approach. This is especially useful in patients of multiple myeloma where high dose melphalan has a short half life and the stem cells are to be reinfused within 2 to 3 days. LM 
